Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)
Palestine · Delayed Price · Currency is JOD · Price in USD 4.150
-0.050 (-1.19%)
At close: Aug 14, 2025
Jerusalem Pharmaceuticals Revenue
Jerusalem Pharmaceuticals had revenue of $10.99M USD in the quarter ending June 30, 2025, with 26.68% growth. This brings the company's revenue in the last twelve months to $44.20M, up 17.86% year-over-year. In the year 2024, Jerusalem Pharmaceuticals had annual revenue of $39.82M with 0.42% growth.
Revenue (ttm)
$44.20M
Revenue Growth
+17.86%
P/S Ratio
1.69
Revenue / Employee
$83.24K
Employees
531
Market Cap
52.94M JOD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 39.82M | 168.20K | 0.42% |
| Dec 31, 2023 | 39.65M | -6.49M | -14.06% |
| Dec 31, 2022 | 46.14M | -82.72K | -0.18% |
| Dec 31, 2021 | 46.23M | 9.83M | 27.00% |
| Dec 31, 2020 | 36.40M | 2.31M | 6.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition